SomaLogic, Inc., established in 1999 and based in Boulder, Colorado, is a prominent player in the United States specializing in the identification of protein biomarkers and clinical diagnostic solutions. The company's core technological offering centers on its proprietary slow off-rate modified aptamers, known as SOMAmers – these are uniquely engineered nucleic acid-based reagents designed for precise protein binding. Complementing this, SomaLogic provides SomaScan services, a platform that enables the high-throughput detection and quantification of numerous protein levels within diverse and complex biological samples.